A global study published in Circulation (2014) analyzed the epidemiology of atrial fibrillation (AF) from 1990 to 2010. The study estimated that in 2010, there were 33.5 million people globally with AF, including 20.9 million males and 12.6 million females. The age-adjusted prevalence of AF increased from 569.5 per 100,000 in males and 359.9 per 100,000 in females in 1990 to 596.2 and 373.1 per 100,000, respectively, in 2010. The incidence of AF also increased, from 60.7 per 100,000 person-years in males and 43.8 in females in 1990 to 77.5 and 59.5 in 2010. Mortality associated with AF increased significantly, with a 2-fold increase in males and a 1.9-fold increase in females from 1990 to 2010. The study found that AF burden, measured in disability-adjusted life-years (DALYs), increased by 18.8% in males and 18.9% in females over the same period. The study highlights the growing global burden of AF, with higher prevalence and incidence in developed countries compared to developing countries. The findings emphasize the need for systematic global surveillance of AF to better direct prevention and treatment strategies. The study also notes that AF is a significant public health problem, with substantial economic costs and a high burden of disease. The study concludes that there is a need for improved surveillance and targeted prevention strategies to address the increasing global burden of AF.A global study published in Circulation (2014) analyzed the epidemiology of atrial fibrillation (AF) from 1990 to 2010. The study estimated that in 2010, there were 33.5 million people globally with AF, including 20.9 million males and 12.6 million females. The age-adjusted prevalence of AF increased from 569.5 per 100,000 in males and 359.9 per 100,000 in females in 1990 to 596.2 and 373.1 per 100,000, respectively, in 2010. The incidence of AF also increased, from 60.7 per 100,000 person-years in males and 43.8 in females in 1990 to 77.5 and 59.5 in 2010. Mortality associated with AF increased significantly, with a 2-fold increase in males and a 1.9-fold increase in females from 1990 to 2010. The study found that AF burden, measured in disability-adjusted life-years (DALYs), increased by 18.8% in males and 18.9% in females over the same period. The study highlights the growing global burden of AF, with higher prevalence and incidence in developed countries compared to developing countries. The findings emphasize the need for systematic global surveillance of AF to better direct prevention and treatment strategies. The study also notes that AF is a significant public health problem, with substantial economic costs and a high burden of disease. The study concludes that there is a need for improved surveillance and targeted prevention strategies to address the increasing global burden of AF.